» Articles » PMID: 32754334

Sporadic Pediatric Severe Familial Adenomatous Polyposis: A Case Report

Overview
Journal Mol Clin Oncol
Specialty Oncology
Date 2020 Aug 6
PMID 32754334
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Familial adenomatous polyposis (FAP) is an autosomal dominant hereditary precancerous condition caused by germline pathogenetic variants in the tumor suppressor adenomatous polyposis coli () gene. Patients with FAP develop multiple gastrointestinal adenomatous polyps usually at the age of ~20 years, which, if untreated, become cancerous in 100% of cases. Genotype-phenotype associations have been extensively described; however, inter- and intra-familial variability exists. It is crucial to characterize the causative pathogenetic variant in each pedigree in order to develop a cancer prevention program and follow-up strategy for at-risk families. The present report describes a severe case of sporadic FAP that was diagnosed when the patient was ~2 years old. The patient was a carrier of the pathogenic c.4132 C>T (p.Gln1378X) variant. Additionally, the patient was a carrier of the homozygous c.5465 T>A (p.Asp1822Val) polymorphism, inherited from both parents. However, it remains unclear whether or not this polymorphism is involved in the phenotypic manifestation. This case highlights the need to extend molecular screening to very young children when they show iron-deficiency, anaemia and/or rectal bleeding, even in the absence of a familial history of disease.

Citing Articles

First Evidence of Familial Transmission of Hereditary Gastrointestinal Polyposis Associated with Germline Variant in Jack Russell Terriers.

Yoneji W, Yoshizaki K, Hirota T, Yoneji K, Yoshikawa R, Mori T Vet Sci. 2023; 10(7).

PMID: 37505844 PMC: 10385476. DOI: 10.3390/vetsci10070439.


The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation.

Turano M, Vicidomini R, Cammarota F, DAgostino V, Duraturo F, Izzo P Biomedicines. 2023; 11(5).

PMID: 37239099 PMC: 10216699. DOI: 10.3390/biomedicines11051428.


Mutational screening through comprehensive bioinformatics analysis to detect novel germline mutations in the APC gene in patients with familial adenomatous polyposis (FAP).

Ghadamyari F, Heidari M, Zeinali S, Khatami M, Merat S, Bagherian H J Clin Lab Anal. 2021; 35(5):e23768.

PMID: 33769591 PMC: 8128300. DOI: 10.1002/jcla.23768.

References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Fernandez-Rozadilla C, De Castro L, Clofent J, Brea-Fernandez A, Bessa X, Abuli A . Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohort. PLoS One. 2010; 5(9). PMC: 2936577. DOI: 10.1371/journal.pone.0012673. View

3.
Picelli S, Zajac P, Zhou X, Edler D, Lenander C, Dalen J . Common variants in human CRC genes as low-risk alleles. Eur J Cancer. 2010; 46(6):1041-8. DOI: 10.1016/j.ejca.2010.01.013. View

4.
Nagase H, Nakamura Y . Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat. 1993; 2(6):425-34. DOI: 10.1002/humu.1380020602. View

5.
Septer S, Lawson C, Anant S, Attard T . Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate. Fam Cancer. 2016; 15(3):477-85. DOI: 10.1007/s10689-016-9905-5. View